Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 2891-2895, August 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Momparler, R. L.
Right arrow Articles by Avila, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Momparler, R. L.
Right arrow Articles by Avila, F.

Effect of Adriamycin on DNA, RNA, and Protein Synthesis in Cell-free Systems and Intact Cells1

Richard L. Momparler, Myron Karon2, Stuart E. Siegel and Felicidad Avila

Department of Pediatrics, University of Southern California School of Medicine, Los Angeles 90033, and Division of Hematology-Oncology, Childrens Hospital of Los Angeles, Los Angeles, California 90027

The effect of adriamycin on DNA, RNA, and protein synthesis was investigated in cell-free systems and intact cells. In studies with purified mammalian cell enzymes, adriamycin produced a greater inhibition of DNA-dependent DNA polymerase than of RNA polymerase. The extent of inhibition of both these enzymes was decreased by increasing the concentration of the DNA template in the reaction mixture. In studies with isolated nuclei, adriamycin was also a more potent inhibitor of DNA synthesis than of RNA synthesis. However, with intact cells, adriamycin inhibited both DNA and RNA synthesis to about the same extent. The inhibition produced by adriamycin on RNA synthesis in intact cells was greater than that observed in the cell-free systems. Adriamycin inhibited protein synthesis in a cell-free system consisting of polyribosomes, transfer RNA, and enzymes but did not inhibit protein synthesis in intact cells. These differences in the pattern of inhibition may be due to biotransformation of the drug and/or preferential binding to chromosomal DNA in the intact cell.

1 This investigation was supported by Grant CI-85-D from the American Cancer Society and USPHS Grant CA-11050 from the National Cancer Institute.

2 Scholar of Leukemia Society of America. Deceased November 16, 1974.

Received 1/ 5/76. Accepted 4/23/76.




This article has been cited by other articles:


Home page
RNAHome page
J. CHAN, S. N. KHAN, I. HARVEY, W. MERRICK, and J. PELLETIER
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles
RNA, March 1, 2004; 10(3): 528 - 543.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. J. Cashman, J. N. Scarsdale, and G. E. Kellogg
Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA
Nucleic Acids Res., August 1, 2003; 31(15): 4410 - 4416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.